(Reuters) – AbbVie Inc is leaving Pharmaceutical Research and Manufacturers of America (PhRMA), the leading U.S. drug industry group said on Thursday. Politico, which first reported on AbbVie’s exit, said…
By Brendan Pierson (Reuters) – Teva Pharmaceutical Industries Ltd and AbbVie Inc have finalized the terms of settlements worth more than $6.6 billion to resolve thousands of lawsuits by U.S.…
(Reuters) -AbbVie Inc on Friday missed Wall Street estimates for quarterly sales, hurt by weaker-than-expected revenue from its popular facial filler Juvederm and blockbuster anti-wrinkle injection Botox. North Chicago, Illinois-based…
(Reuters) – Drugmakers Bristol Myers Squibb Co and AbbVie Inc told California officials that they plan to cut up to 360 jobs there in unrelated moves, according to notices filed…
By Michael Erman (Reuters) – Drugmaker AbbVie Inc generates most of its sales in the United States, while shifting most of its profits overseas in order to avoid U.S. taxes,…
By Michael Erman (Reuters) – Johnson & Johnson and AbbVie’s big-selling leukemia drug Imbruvica in combination with standard treatment kept a rare type of non-Hodgkin lymphoma in check for more…